Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pau Serra

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
BMC Medicine|June 29, 2021
Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19Carlota Dobaño, Anna Ramírez-Morros, Selena Alonso, et al.
Nature|February 18, 2016
Expanding antigen-specific regulatory networks to treat autoimmunityXavier Clemente-Casares, Jesus Blanco, Poornima Ambalavanan, et al.
Nature Communications|December 13, 2025
Primary SARS-CoV-2 exposure by vaccination or infection shapes immune responses to omicron variants among a Spanish cohortOtavio Ranzani, Carla Martín Pérez, Rocío Rubio, et al.
BMC Medicine|March 8, 2024
Correlates of protection and determinants of SARS-CoV-2 breakthrough infections 1 year after third dose vaccinationCarla Martín Pérez, Ruth Aguilar, Alfons Jiménez, et al.
Journal of Clinical Microbiology|October 31, 2020
Highly Sensitive and Specific Multiplex Antibody Assays To Quantify Immunoglobulins M, A, and G against SARS-CoV-2 AntigensCarlota Dobaño, Marta Vidal, Rebeca Santano, et al.
Cell|October 21, 2017
A Gut Microbial Mimic that Hijacks Diabetogenic Autoreactivity to Suppress ColitisRoopa Hebbandi Nanjundappa, Francesca Ronchi, Jinguo Wang, et al.
Cell Reports|April 2, 2025
Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemicLuis M Molinos-Albert, Rocío Rubio, Carla Martín-Pérez, et al.
Nature Nanotechnology|April 25, 2017
Peptide-MHC-based nanomedicines for autoimmunity function as T-cell receptor microclustering devicesSantiswarup Singha, Kun Shao, Yang Yang, et al.
Environmental Health Perspectives|April 5, 2023
Long-Term Exposure to Air Pollution and COVID-19 Vaccine Antibody Response in a General Population Cohort (COVICAT Study, Catalonia)Manolis Kogevinas, Marianna Karachaliou, Ana Espinosa, et al.
BMC Medicine|September 15, 2022
SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in CataloniaMarianna Karachaliou, Gemma Moncunill, Ana Espinosa, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
BMC Medicine|June 29, 2021
Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19Carlota Dobaño, Anna Ramírez-Morros, Selena Alonso, et al.
Nature|February 18, 2016
Expanding antigen-specific regulatory networks to treat autoimmunityXavier Clemente-Casares, Jesus Blanco, Poornima Ambalavanan, et al.
Nature Communications|December 13, 2025
Primary SARS-CoV-2 exposure by vaccination or infection shapes immune responses to omicron variants among a Spanish cohortOtavio Ranzani, Carla Martín Pérez, Rocío Rubio, et al.
BMC Medicine|March 8, 2024
Correlates of protection and determinants of SARS-CoV-2 breakthrough infections 1 year after third dose vaccinationCarla Martín Pérez, Ruth Aguilar, Alfons Jiménez, et al.
Journal of Clinical Microbiology|October 31, 2020
Highly Sensitive and Specific Multiplex Antibody Assays To Quantify Immunoglobulins M, A, and G against SARS-CoV-2 AntigensCarlota Dobaño, Marta Vidal, Rebeca Santano, et al.
Cell|October 21, 2017
A Gut Microbial Mimic that Hijacks Diabetogenic Autoreactivity to Suppress ColitisRoopa Hebbandi Nanjundappa, Francesca Ronchi, Jinguo Wang, et al.
Cell Reports|April 2, 2025
Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemicLuis M Molinos-Albert, Rocío Rubio, Carla Martín-Pérez, et al.
Nature Nanotechnology|April 25, 2017
Peptide-MHC-based nanomedicines for autoimmunity function as T-cell receptor microclustering devicesSantiswarup Singha, Kun Shao, Yang Yang, et al.
Environmental Health Perspectives|April 5, 2023
Long-Term Exposure to Air Pollution and COVID-19 Vaccine Antibody Response in a General Population Cohort (COVICAT Study, Catalonia)Manolis Kogevinas, Marianna Karachaliou, Ana Espinosa, et al.
BMC Medicine|September 15, 2022
SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in CataloniaMarianna Karachaliou, Gemma Moncunill, Ana Espinosa, et al.
Pageof 6